Rapid Micro Biosystems Inc (RPID) - Total Assets
Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) holds total assets worth $74.85 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Rapid Micro Biosystems Inc (RPID) net assets for net asset value and shareholders' equity analysis.
Rapid Micro Biosystems Inc - Total Assets Trend (2010–2025)
This chart illustrates how Rapid Micro Biosystems Inc's total assets have evolved over time, based on quarterly financial data.
Rapid Micro Biosystems Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Rapid Micro Biosystems Inc's total assets of $74.85 Million consist of 81.7% current assets and 18.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.8% |
| Accounts Receivable | $3.13 Million | 4.2% |
| Inventory | $17.59 Million | 23.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Rapid Micro Biosystems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Rapid Micro Biosystems Inc (RPID) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rapid Micro Biosystems Inc's current assets represent 81.7% of total assets in 2025, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 26.8% of total assets in 2025, up from 6.7% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 49.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 23.5% of total assets.
Rapid Micro Biosystems Inc Competitors by Total Assets
Key competitors of Rapid Micro Biosystems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Rapid Micro Biosystems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.31 | 4.61 | 8.97 |
| Quick Ratio | 2.36 | 3.46 | 8.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $42.68 Million | $63.35 Million | $115.38 Million |
Rapid Micro Biosystems Inc - Advanced Valuation Insights
This section examines the relationship between Rapid Micro Biosystems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.12 |
| Latest Market Cap to Assets Ratio | 1.38 |
| Asset Growth Rate (YoY) | -23.8% |
| Total Assets | $74.85 Million |
| Market Capitalization | $103.64 Million USD |
Valuation Analysis
Above Book Valuation: The market values Rapid Micro Biosystems Inc's assets above their book value (1.38x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Rapid Micro Biosystems Inc's assets decreased by 23.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Rapid Micro Biosystems Inc (2010–2025)
The table below shows the annual total assets of Rapid Micro Biosystems Inc from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $74.85 Million | -23.75% |
| 2024-12-31 | $98.17 Million | -31.57% |
| 2023-12-31 | $143.45 Million | -24.76% |
| 2022-12-31 | $190.65 Million | -20.95% |
| 2021-12-31 | $241.17 Million | +244.54% |
| 2020-12-31 | $70.00 Million | +120.89% |
| 2019-12-31 | $31.69 Million | +1805.47% |
| 2011-12-31 | $1.66 Million | -28.29% |
| 2010-12-31 | $2.32 Million | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more